In a colorectal tumor model, tumor-specific CD4+ T cells derived from TCR transgenic (TCR-Tg) mice were used, modeling the clinical use of selected tumor-reactive T cell clones or T cells engineered to express tumor-specific TCRs. The gene discussed is CD4; the disease is neoplasm.